Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression: a retrospective selected-lesion study
- 1Department of CT Radiology, The First Hospital of Shanxi Medical University
- 2College of Medical Imaging, Shanxi Medical University
Abstract
Background: Coronary disease that is non-obstructive at baseline may progress, while luminal stenosis alone does not capture local pericoronary tissue characteristics or lesion-specific functional impairment.
Objective: To assess associations of lesion-specific pericoronary adipose tissue (PCAT) attenuation and CT-derived fractional flow reserve (CT-FFR) with imaging-defined stenosis progression and to evaluate an exploratory multivariable model.
Methods: This retrospective single-center study included 201 patients undergoing serial coronary computed tomography angiography with selected target lesions classified as minimal or mild at baseline. In progressors, the lesion with the greatest follow-up progression was selected; in non-progressors, the lesion with the greatest baseline stenosis was selected. Thus, target-lesion selection was outcome dependent. Lesion-specific PCAT and CT-FFR were quantified using dedicated automated software after target-lesion identification. Five logistic models specified before reanalysis fitting were fitted in a common complete-case population ( n = 191), and Model E retained nine predictors. Internal performance was assessed with 2,000 patient-level bootstrap resamples.
Results: Progression occurred in 115 of 201 patients. In Model E, less-negative PCAT attenuation (odds ratio [OR] per 10-HU increase, 1.552; 95% CI, 1.137–2.119; P = 0.006) and lower CT-FFR (OR per 0.05 decrease, 1.360; 95% CI, 1.041–1.778; P = 0.024) were associated with progression; age showed an inverse conditional association (OR per 10-year increase, 0.509; 95% CI, 0.346–0.749; P < 0.001). Model E had an apparent AUC of 0.767 (95% CI, 0.700–0.834) and an optimism-corrected AUC of 0.722 (95% bootstrap interval, 0.659–0.787). The corrected Brier score was 0.217 (0.189–0.251), calibration intercept −0.0002 (−0.354 to 0.361), and calibration slope 0.779 (0.539–1.100). Versus Model B, corrected Δ AUC was 0.053 (−0.005 to 0.088), indicating apparent improvement with uncertainty.
Conclusions: Less-negative lesion-specific PCAT attenuation and lower CT-FFR were associated with imaging-defined stenosis progression. The combined model showed moderate optimism-corrected discrimination, but incremental discrimination remained uncertain. Because lesion selection in progressors incorporated follow-up information and no external validation was available, this internally derived model is exploratory and is not a clinically validated decision tool.
Related
- Elevated pericoronary adipose tissue attenuation assessed by fat attenuation index in atrial fibrillation without cardiovascular comorbidities: a retrospective observational study
- Computed Tomography Angiography-Derived Pericoronary Fat Attenuation Index and AI-Based Cardiovascular Risk Score as a Proposed New Pathway in a Rapid Access Chest Pain Clinic: A Single-Centre Retrospective Registry Study
- Deep learning–based quantification of muscle volume and attenuation and their associations with preinjury ambulatory status in patients with hip fractures
- Perivascular fat attenuation index improves the identification of functional myocardial ischemia beyond traditional risk factors: a coronary CT angiography-derived fractional flow reserve study
- Associations of multiregional OCTA metrics and systemic hematologic biomarkers With 12-month diabetic retinopathy progression
BibTeX
@article{wang2026associations,
title = {{Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression: a retrospective selected-lesion study}},
author = {Jun Wang and Kenan Song and Sheng He and Suping Chen and Yanjun Hou and Wenqing Chen and Jian Liu and Li Feng and Wenfeng Wei and Zengyu Jiang},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
month = nov,
doi = {10.3389/fcvm.2026.1954142},
url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1954142/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Associations of lesion-specific pericoronary adipose tissue attenuation and CT-derived fractional flow reserve with coronary stenosis progression: a retrospective selected-lesion study
AU - Jun Wang
AU - Kenan Song
AU - Sheng He
AU - Suping Chen
AU - Yanjun Hou
AU - Wenqing Chen
AU - Jian Liu
AU - Li Feng
AU - Wenfeng Wei
AU - Zengyu Jiang
PY - 2026
DA - 2026/11/09
JO - Frontiers in Cardiovascular Medicine
DO - 10.3389/fcvm.2026.1954142
UR - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1954142/full
AB - Background: Coronary disease that is non-obstructive at baseline may progress, while luminal stenosis alone does not capture local pericoronary tissue characteristics or lesion-specific functional impairment. Objective: To assess associations of lesion-specific pericoronary adipose tissue (PCAT) attenuation and CT-derived fractional flow reserve (CT-FFR) with imaging-defined stenosis progression and to evaluate an exploratory multivariable model. Methods: This retrospective single-center study included 201 patients undergoing serial coronary computed tomography angiography with selected target lesions classified as minimal or mild at baseline. In progressors, the lesion with the greatest follow-up progression was selected; in non-progressors, the lesion with the greatest baseline stenosis was selected. Thus, target-lesion selection was outcome dependent. Lesion-specific PCAT and CT-FFR were quantified using dedicated automated software after target-lesion identification. Five logistic models specified before reanalysis fitting were fitted in a common complete-case population ( n = 191), and Model E retained nine predictors. Internal performance was assessed with 2,000 patient-level bootstrap resamples. Results: Progression occurred in 115 of 201 patients. In Model E, less-negative PCAT attenuation (odds ratio [OR] per 10-HU increase, 1.552; 95% CI, 1.137–2.119; P = 0.006) and lower CT-FFR (OR per 0.05 decrease, 1.360; 95% CI, 1.041–1.778; P = 0.024) were associated with progression; age showed an inverse conditional association (OR per 10-year increase, 0.509; 95% CI, 0.346–0.749; P < 0.001). Model E had an apparent AUC of 0.767 (95% CI, 0.700–0.834) and an optimism-corrected AUC of 0.722 (95% bootstrap interval, 0.659–0.787). The corrected Brier score was 0.217 (0.189–0.251), calibration intercept −0.0002 (−0.354 to 0.361), and calibration slope 0.779 (0.539–1.100). Versus Model B, corrected Δ AUC was 0.053 (−0.005 to 0.088), indicating apparent improvement with uncertainty. Conclusions: Less-negative lesion-specific PCAT attenuation and lower CT-FFR were associated with imaging-defined stenosis progression. The combined model showed moderate optimism-corrected discrimination, but incremental discrimination remained uncertain. Because lesion selection in progressors incorporated follow-up information and no external validation was available, this internally derived model is exploratory and is not a clinically validated decision tool.
SN - 2297-055X
ER -